BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
17 results:

  • 1. Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis.
    Chatterjee S; Sanjeev BS
    Microb Pathog; 2023 Jul; 180():106115. PubMed ID: 37137346
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
    Braggio DA; Costas C de Faria F; Koller D; Jin F; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Horrigan SK; Han R; Larson JL; Strohecker AM; Pollock RE
    PLoS One; 2022; 17(10):e0276047. PubMed ID: 36240209
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting axin2 and modulating the Wnt/β-catenin pathway.
    Liu Z; Zhong L; Dan W; Chu X; Liu C; Luo X; Zhang Z; Lu Y; Wan P; Wang X; Liu B
    Biochem Biophys Res Commun; 2022 Sep; 620():83-91. PubMed ID: 35780585
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.
    Llimos G; Gardeux V; Koch U; Kribelbauer JF; Hafner A; Alpern D; Pezoldt J; Litovchenko M; Russeil J; Dainese R; Moia R; Mahmoud AM; Rossi D; Gaidano G; Plass C; Lutsik P; Gerhauser C; Waszak SM; Boettiger A; Radtke F; Deplancke B
    Nat Commun; 2022 Apr; 13(1):2042. PubMed ID: 35440565
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Understanding the Molecular Mechanisms of Betel miRNAs on Human Health.
    Manvar T; Mangukia N; Patel S; Rawal R
    Microrna; 2022; 11(1):45-56. PubMed ID: 35307000
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia.
    Fatima M; Kakar SJ; Adnan F; Khan K; Mian AA; Khan D
    BMC Cancer; 2021 Jun; 21(1):713. PubMed ID: 34140003
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular structure, expression, and functional role of Clec11a in skeletal biology and cancers.
    Wang M; Guo J; Zhang L; Kuek V; Xu J; Zou J
    J Cell Physiol; 2020 Oct; 235(10):6357-6365. PubMed ID: 32003015
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Revisiting β-Catenin Signaling in T-Cell Development and T-Cell Acute Lymphoblastic leukemia.
    Bigas A; Guillén Y; Schoch L; Arambilet D
    Bioessays; 2020 Feb; 42(2):e1900099. PubMed ID: 31854474
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Wnt Signalling in Acute Myeloid Leukaemia.
    Gruszka AM; Valli D; Alcalay M
    Cells; 2019 Nov; 8(11):. PubMed ID: 31703382
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling.
    Liu X; Liu S; Chen J; He L; Meng X; Liu S
    Ann Hematol; 2016 Oct; 95(11):1787-93. PubMed ID: 27506924
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Genetic Polymorphisms in Wnt Signaling Pathway and Acute leukemia].
    Zhang LJ; Zhou J; Ye YX; Lu XJ; Jiang H; Mao ZG; Zeng SG; Ying BW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):403-8. PubMed ID: 26121862
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An integrated approach of gene expression and DNA-methylation profiles of WNT signaling genes uncovers novel prognostic markers in acute myeloid leukemia.
    Taskesen E; Staal FJ; Reinders MJ
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S4. PubMed ID: 25734857
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ponatinib induces apoptosis in imatinib-resistant human mast cells by dephosphorylating mutant D816V KIT and silencing β-catenin signaling.
    Jin B; Ding K; Pan J
    Mol Cancer Ther; 2014 May; 13(5):1217-30. PubMed ID: 24552773
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The (pro)renin receptor ((P)RR) can act as a repressor of Wnt signalling.
    Bernhard SM; Seidel K; Schmitz J; Klare S; Kirsch S; Schrezenmeier E; Zaade D; Meyborg H; Goldin-Lang P; Stawowy P; Zollmann FS; Unger T; Funke-Kaiser H
    Biochem Pharmacol; 2012 Dec; 84(12):1643-50. PubMed ID: 23022225
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.
    Yang GB; Barnholtz-Sloan JS; Chen Y; Bordeaux JS
    Arch Dermatol; 2011 Dec; 147(12):1395-402. PubMed ID: 22184761
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
    Song S; Christova T; Perusini S; Alizadeh S; Bao RY; Miller BW; Hurren R; Jitkova Y; Gronda M; Isaac M; Joseph B; Subramaniam R; Aman A; Chau A; Hogge DE; Weir SJ; Kasper J; Schimmer AD; Al-awar R; Wrana JL; Attisano L
    Cancer Res; 2011 Dec; 71(24):7628-39. PubMed ID: 22009536
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. AXIS inhibition protein 2, orofacial clefts and a family history of cancer.
    Menezes R; Marazita ML; Goldstein McHenry T; Cooper ME; Bardi K; Brandon C; Letra A; Martin RA; Vieira AR
    J Am Dent Assoc; 2009 Jan; 140(1):80-4. PubMed ID: 19119171
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.